Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRPT | AMGN | BMY | GILD | VRTX |
| Company | Sarepta Therapeutics | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 20.97 | 329.95 | 54.10 | 123.73 | 440.54 |
| High | 21.88 | 343.98 | 54.62 | 129.39 | 465.14 |
| Low | 20.90 | 329.32 | 53.54 | 122.68 | 439.91 |
| Latest | 21.37 | 343.60 | 54.50 | 129.11 | 461.14 |
| Change | +0.33 | +12.60 | +0.28 | +4.97 | +19.06 |
| % Change | +1.57% | +3.81% | +0.52% | +4.00% | +4.31% |
| Volume | 2,271,962 | 4,147,770 | 15,692,277 | 7,282,289 | 2,288,821 |
| 20-Day Average Volume | 2,686,308 | 2,297,203 | 12,985,824 | 5,718,034 | 1,256,116 |
| Previous Close | 21.04 | 331.00 | 54.22 | 124.14 | 442.08 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 21.90 | 330.28 | 54.96 | 123.29 | 457.38 |
| 20-Day Raw Stochastic | 31.59% | 98.53% | 49.00% | 97.76% | 54.92% |
| 20-Day Relative Strength | 49.74 | 60.47 | 55.51 | 58.94 | 54.99 |
| Weighted Alpha | -50.09 | +27.47 | +0.43 | +36.64 | +7.61 |
| Today's Opinion | 24% Buy | 88% Buy | 80% Buy | 96% Buy | 72% Buy |
| Previous Opinion | 24% Buy | 80% Buy | 80% Buy | 72% Buy | 40% Buy |
| Last Month's Opinion | 32% Sell | 72% Buy | 72% Buy | 56% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.42% since 01/13/26 | +5.95% since 01/13/26 | -2.54% since 01/13/26 | +6.04% since 01/13/26 | +1.42% since 01/13/26 |
| Low | 20.10 on 01/20/26 | 321.71 on 01/20/26 | 53.54 on 01/21/26 | 120.94 on 01/15/26 | 429.00 on 01/20/26 |
| High | 23.00 on 01/14/26 | 343.98 on 01/21/26 | 57.04 on 01/14/26 | 129.39 on 01/21/26 | 465.14 on 01/21/26 |
| 1-Month | |||||
| %Chg | +1.57% since 12/19/25 | +4.95% since 12/19/25 | +0.57% since 12/19/25 | +3.88% since 12/19/25 | +1.08% since 12/19/25 |
| Low | 20.10 on 01/20/26 | 318.21 on 01/05/26 | 52.06 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 24.12 on 01/08/26 | 343.98 on 01/21/26 | 57.04 on 01/14/26 | 129.39 on 01/21/26 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | -8.48% since 10/21/25 | +14.10% since 10/21/25 | +22.36% since 10/21/25 | +4.05% since 10/21/25 | +8.18% since 10/21/25 |
| Low | 15.08 on 11/04/25 | 288.00 on 10/31/25 | 42.52 on 10/29/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 24.55 on 11/03/25 | 346.38 on 12/03/25 | 57.04 on 01/14/26 | 129.39 on 01/21/26 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +60.44% since 07/21/25 | +16.13% since 07/21/25 | +16.73% since 07/21/25 | +19.24% since 07/21/25 | +0.58% since 07/21/25 |
| Low | 10.41 on 07/24/25 | 269.77 on 09/26/25 | 42.52 on 10/29/25 | 108.06 on 07/22/25 | 362.50 on 08/11/25 |
| High | 25.32 on 10/08/25 | 346.38 on 12/03/25 | 57.04 on 01/14/26 | 129.39 on 01/21/26 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,204,719 | 178,237,216 | 110,378,528 | 154,018,016 | 112,164,088 |
| Shares Outstanding, K | 104,787 | 538,481 | 2,035,753 | 1,240,680 | 253,719 |
| Annual Sales | 1,901,980,000 | 33,424,000,000 | 48,300,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | 235,240,000 | 4,090,000,000 | -8,948,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 399,360,000 | 9,557,000,000 | 12,222,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -179,950,000 | 3,216,000,000 | 2,201,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.48 | 0.45 | 0.29 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.13 on 11/03/25 | 5.64 on 11/04/25 | 1.63 on 10/30/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 02/25/26 | 02/03/26 | 02/05/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 2.380 on 11/21/25 | 0.630 on 01/02/26 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/13/26 | 01/02/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.11 | 8.42 | 15.25 | 28.83 |